Výsledky vyhledávání

Akademický článek

Association of HER-2/CEP17 Ratio and HER-2 Copy Number With pCR Rate in HER-2-Positive Breast Cancer After Dual-Target Neoadjuvant Therapy With Trastuzumab and Pertuzumab

Autor: Fanfan Li, Qian Ju, Cong Gao, Jingjing Li, Xiaolei Wang, Min Yan, Liying Zhang, Meiling Huang, Qihe Long, Xiangting Jin, Nanlin Li

Publikováno v: Frontiers in Oncology, Vol 12 (2022)

ObjectiveTo explore the correlation between HER-2 status and pathological complete response (pCR) in HER-2-positive breast cancer after dual anti-HER-2 neoadjuvant therapy with trastuzumab and pertuzumab.MethodsA total of 57 HER-2-positive breast can

Externí odkaz: https://doaj.org/article/f85291b8604d4de9a349c8d201d80d49

Zobrazit plný text záznamu

HLX11, a Proposed Pertuzumab Biosimilar: Pharmacokinetics, Immunogenicity, and Safety Profiles Compared to Three Reference Biologic Products (US-, EU-, and CN-Approved Pertuzumab) Administered to Healthy Male Subjects

Autor: Jingjing Yang, Lili Lin, Qihe Long, Qian Zhang, Guilan Sun, Liang Zhou, Qingyu Wang, Jun Zhu, Fanfan Li, Wei Hu

Publikováno v: BioDrugs. 36:393-409

Pertuzumab is a humanized monoclonal antibody for the treatment of breast cancer. HLX11 is a biosimilar of pertuzumab developed by Shanghai Henlius Biotech, Inc. We conducted a bioequivalence study for HLX11 and pertuzumab (United States [US]-, Europ

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::937f93aef471515591897cf1b560e82e
https://doi.org/10.1007/s40259-022-00534-w

Zobrazit plný text záznamu

Clinical Outcomes of Patients with Advanced Solid Tumors of Cutaneous Capillary Hyperplasia Following Treatment with Camrelizumab: A Retrospective Case-Control Study

Autor: Jun yang zhao, Yu Su, Fanfan Li, Xiaolei Wang, Qihe Long, Qian He, Jingjing Li

Publikováno v: Journal of Disease Markers. 6

Objective: To investigate the difference of clinical outcomes between patients with and without Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP) after camrelizumab treatment. Methods: A retrospective, matched case-control study was desi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::22aad3b84060d36f7b54507d1ef6c030
https://doi.org/10.26420/jdismarkers.2021.1044

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání